Ipamorelin Thailand — Buy 10mg Research Peptide in Bangkok
Ipamorelin is a high-purity, lyophilised research peptide supplied locally in Bangkok and across Thailand for laboratory and preclinical research use only. A synthetic pentapeptide originally developed by Novo Nordisk in the 1990s, Ipamorelin is one of the most selective growth hormone secretagogues in published research literature — referenced extensively in studies of pulsatile GH release, ghrelin/GHS receptor signalling, and endocrine pathway modelling.
Bangkok Peptides supplies Ipamorelin in a 10mg single-vial format with HPLC/MS verified purity and third-party Janoshik Analytical reporting. Researchers in Thailand can buy Ipamorelin with same-day dispatch from Bangkok and tracked nationwide delivery to Phuket, Pattaya, Chiang Mai, Hua Hin, Koh Samui, and beyond.
Product Specifications
+
- Product: Ipamorelin
- CAS Number: 170851-70-4
- Alternative Names: NNC 26-0161, Growth Hormone Secretagogue Pentapeptide
- Classification: Synthetic pentapeptide, ghrelin/GHS receptor agonist
- Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Molecular Formula: C38H49N9O5
- Molecular Weight: 711.86 g/mol
- PubChem CID: 9831659
- Form: Lyophilised white/off-white powder
- Purity: ≥99% (HPLC/MS verified)
- Vial Strength: 10mg
- Vial Size: 3ml
- Solubility: Reconstitutable with bacteriostatic water
- Storage: Cool, dry, protected from light
- Third-Party Testing: Janoshik Analytical reports available
- Intended Use: Laboratory research only
Why Bangkok Peptides
≥99% Purity
HPLC/MS verified purity standards across every batch produced under controlled laboratory conditions.
Janoshik Tested
Independent third-party purity verification published per batch where available.
Bangkok Dispatch
Same-day or next-day dispatch from Bangkok, with tracked nationwide delivery across Thailand.
Discreet Packaging
Sealed, tamper-evident vials shipped in plain packaging with responsive native English support.
About Ipamorelin
Ipamorelin is a synthetic pentapeptide composed of five amino acids — Aib-His-D-2-Nal-D-Phe-Lys-NH2 — including two non-standard residues (aminoisobutyric acid and D-2-naphthylalanine) that distinguish it from naturally occurring peptides. It was developed by Novo Nordisk and first described by Raun et al. in a landmark 1998 European Journal of Endocrinology paper as the first selective growth hormone secretagogue.
In the published research literature, what distinguishes Ipamorelin from earlier GH secretagogues (GHRP-2, GHRP-6, hexarelin) is its hormonal specificity. Ipamorelin engages the ghrelin/GHS receptor to stimulate pulsatile growth hormone release without significantly elevating ACTH, cortisol, or prolactin — a selectivity profile that made it the standard reference compound for clean GH-pathway research.
Ipamorelin is most often paired in research with GHRH analogues such as CJC-1295, since the two compounds engage complementary pathways — GHRH analogues acting at the GHRH receptor and Ipamorelin at the ghrelin/GHS receptor. Combined research models examine the additive or synergistic effects of activating both receptor systems.
CAS Number: 170851-70-4
Vial Specification
10mg
3ml Sterile Vial
Standard Research Format
Ipamorelin & CJC-1295 — The GH Pathway Pairing
Ipamorelin and CJC-1295 are the most frequently paired peptides in published growth hormone pathway research. The two compounds engage distinct but complementary receptor systems:
- Ipamorelin: Pentapeptide ghrelin/GHS receptor agonist — selective for GH release without significant ACTH, cortisol, or prolactin elevation
- CJC-1295: GHRH analogue acting at the GHRH receptor on pituitary somatotrophs
- Combined research: Studies of pulsatile GH release frequently pair both compounds to examine synergistic effects across the two receptor pathways
Bangkok Peptides supplies Ipamorelin individually as a 10mg vial and also stocks the pre-blended CJC-1295 / Ipamorelin combination for researchers using both compounds together.
Research Background
Ipamorelin has been examined extensively in published preclinical research literature since its first description by Raun et al. in 1998. Its high receptor selectivity makes it a preferred reference compound for cleanly isolating GH-pathway effects without interference from cortisol or prolactin elevation. The research footprint spans:
- Pulsatile GH release research: The compound’s selectivity profile makes it a clean tool for studying ghrelin/GHS receptor activation
- Endocrine-axis modelling: Studies isolating GH pathway effects from broader pituitary responses
- Receptor-selectivity research: Comparator studies versus less selective GH secretagogues (GHRP-2, GHRP-6, hexarelin)
- Combination research: GHRH analogue + GHS pairing studies
- Postoperative ileus research: Phase 2 clinical trials by Helsinn Therapeutics in bowel resection models
For published research summaries, researchers can consult public scientific databases such as PubMed for current peer-reviewed literature.
Handling & Reconstitution
- Reconstitute using sterile bacteriostatic water with 0.9% benzyl alcohol.
- Inject diluent down the inside wall of the vial — do not aim directly at the lyophilised powder.
- Swirl gently — do not shake — until fully dissolved into a clear solution.
- Use only within controlled laboratory environments by qualified researchers.
- Follow standard clean-lab handling and aseptic technique procedures throughout.
Storage Guidelines
- Store lyophilised peptide cool, dry, and protected from direct light.
- Refrigerate reconstituted solutions at 2–8°C — particularly relevant in Thailand’s climate.
- Avoid repeated freeze–thaw cycles, which compromise peptide integrity.
- Lyophilised shelf life is up to 24 months when stored correctly.
Bangkok & Thailand Delivery
Ipamorelin is supplied locally within Thailand from the Bangkok Peptides domestic facility. Orders placed in Bangkok may qualify for same-day collection or motorbike delivery, with tracked nationwide shipping available across Thailand including Phuket, Pattaya, Chiang Mai, Hua Hin, Koh Samui, Krabi, and other regions.
Domestic supply eliminates the customs uncertainty, freight delays, and cold-chain risk associated with importing peptides internationally — a meaningful consideration for researchers in Thailand’s climate, where ambient temperatures can compromise peptide integrity during extended transit.
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. CAS 170851-70-4. It was developed by Novo Nordisk in the 1990s (development code NNC 26-0161) and first described by Raun et al. in 1998 as the first selective growth hormone secretagogue. It engages the ghrelin/GHS receptor to stimulate pulsatile GH release with high specificity, without significantly elevating ACTH, cortisol, or prolactin.
What makes Ipamorelin “selective”?
Earlier growth hormone secretagogues like GHRP-2, GHRP-6, and hexarelin engaged the ghrelin/GHS receptor but also caused significant elevation of cortisol, prolactin, and ACTH alongside GH release. Ipamorelin’s structural design — particularly the inclusion of Aib (aminoisobutyric acid) at the N-terminus and D-2-naphthylalanine in the third position — produces GH release with markedly reduced effects on these other hormones. This selectivity made it the standard reference compound for cleanly isolating GH-pathway effects in published research.
How does Ipamorelin differ from CJC-1295?
Both peptides act on the growth hormone pathway but engage different receptor systems. Ipamorelin is a ghrelin/GHS receptor agonist — a 5-amino-acid pentapeptide. CJC-1295 is a GHRH analogue that acts at the GHRH receptor — a longer modified GHRH-derived sequence. Because they engage complementary pathways, the two compounds are frequently studied together in published research, and Bangkok Peptides supplies them both individually and as a pre-blended combination vial.
Is Ipamorelin supplied for research use only?
Yes. All Ipamorelin supplied by Bangkok Peptides is distributed strictly for laboratory and research purposes only, and is not intended for human or veterinary use. Ipamorelin is not approved as a medicine, supplement, or therapeutic product in any major jurisdiction.
What research areas use Ipamorelin?
Published research literature most frequently references Ipamorelin in models examining pulsatile growth hormone release, ghrelin/GHS receptor signalling, endocrine-axis pharmacology, comparator studies versus less-selective GH secretagogues (GHRP-2, GHRP-6, hexarelin), and combination research with GHRH analogues like CJC-1295. It was also evaluated in Phase 2 clinical trials by Helsinn Therapeutics for postoperative ileus, though that programme was discontinued.
How is Ipamorelin reconstituted?
Ipamorelin is supplied as a lyophilised powder in a sterile 3ml vial and requires reconstitution with sterile bacteriostatic water before research use. Inject the diluent down the inside wall of the vial, swirl gently — do not shake — until fully dissolved into a clear solution. Follow standard aseptic laboratory handling procedures throughout.
Is lab verification available?
Yes. Selected batches of Ipamorelin are independently tested by Janoshik Analytical for purity verification, with reports published on the product page where available. All batches are HPLC/MS verified to ≥99% purity.
Do you supply Ipamorelin in Thailand?
Yes. Bangkok Peptides supplies Ipamorelin within Thailand with dispatch from Bangkok and tracked nationwide delivery to Phuket, Pattaya, Chiang Mai, Hua Hin, Koh Samui and beyond. Same-day collection or motorbike delivery may be available within Bangkok depending on order timing.
How should Ipamorelin be stored?
Lyophilised Ipamorelin should be stored cool, dry, and protected from direct light. Reconstituted solutions should be refrigerated at 2–8°C. Avoid repeated freeze–thaw cycles. Lyophilised shelf life is up to 24 months when stored correctly.
Related Research Peptides
⚠ Important: Supplied strictly for laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. Bacteriostatic water sold separately.
